Radiation Oncology/Therapy: Page 105

Biochemical failure of high-intensity ultrasound for prostate CA redefined
By Reuters Health
NEW YORK (Reuters Health), Oct 16 - An increase in prostate-specific antigen level of 1.2 ng/mL over the nadir should be considered a biochemical failure after high-intensity focused ultrasound for prostate cancer, according to authors of a paper in the October issue of BJU International.
October 15, 2009
Reuterslogo
Siemens reports first Artiste treatment in U.K.
By AuntMinnieEurope.com staff writers
Siemens Healthcare said that the first patient in the U.K. has been treated using its Artiste image-guided radiation therapy system.
September 27, 2009
New European cancer organization established
By AuntMinnieEurope.com staff writers
A new organization called the European Academy of Cancer Sciences has been formed to advocate for cancer patients and to help prevent policy decisions that negatively affect oncology.
September 24, 2009
US can predict survival of melanoma patients
By AuntMinnieEurope.com staff writers
Morphology criteria on ultrasound can be used to determine if cancer has metastasized in melanoma patients and, if so, how much it has spread, according to study results presented this week in Berlin.
September 24, 2009
Radiosensitive patients identified by genetic traits
By AuntMinnieEurope.com staff writers
An international group of scientists has taken the first step toward targeting radiation therapy dosage to individual patients based on their genetic characteristics.
September 24, 2009
Whole-brain radiation for mets may be ineffective
By AuntMinnieEurope.com staff writers
Patients with a limited number of brain metastases and stable primary cancer who receive whole-brain radiation therapy after surgery do not have better survival outcomes than patients who don't receive the treatment, according to study results presented this week in Berlin.
September 23, 2009
Medicare patients have high radiation therapy dropout rates
By Cynthia E. Keen
Nearly half of Medicare patients in the U.S. interrupt or don't complete their prescribed radiation therapy treatments for head and neck cancer, according to a new study published in the September issue of the Archives of Otolaryngology -- Head and Neck Surgery.
September 23, 2009
Early intervention may limit radiation-induced nodules
By Reuters Health
NEW YORK (Reuters Health), Sep 23 - Thyroid nodules are not rare in children after radiation for cancer, Italian researchers report in the September European Journal of Cancer. However, close surveillance and early therapy appear to limit these sequelae.
September 22, 2009
Reuterslogo
Heat-treated tumors respond better to chemotherapy
By Reuters Health
BERLIN (Reuters), Sep 22 - Cancer patients whose tumors are targeted with heat treatment as well as chemotherapy are more likely to stay alive and cancer-free for longer than those who receive only chemotherapy, researchers said on Tuesday.
September 21, 2009
Reuterslogo
Pentoxifylline/vitamin E combo may prevent some radiation side effects
By Reuters Health
NEW YORK (Reuters Health), Sep 18 - The combination of pentoxifylline and vitamin E prevented radiation-induced lymphedema among breast cancer patients in a phase II trial in Sweden.
September 17, 2009
Reuterslogo
Radiation therapy slows return of head/neck cancer
By AuntMinnieEurope.com staff writers
A large, long-term outcomes study conducted in Norway revealed that radiation therapy may actually inhibit premalignant lesions in the upper aerodigestive tract from becoming cancerous for many years.
September 14, 2009
Elekta posts healthy Q1 results
By AuntMinnieEurope.com staff writers
Swedish oncology firm Elekta reports that demand for its clinical products and services remained strong in the first three months of fiscal year 2010.
September 14, 2009
Previous Page
Page 105 of 126
Next Page